Bennie Hau Jeng, MD

Ophthalmology
Accepting new patients
Sees patients age 18 and up
Scheie Eye Institute Penn Presbyterian
Make an appointmentCall 215-662-8100
Headshot of Bennie Hau Jeng, MD
Penn Medicine Provider

About me

  • Chair, Department of Ophthalmology
  • Director, Scheie Eye Institute at Penn Medicine
  • William F. Norris and George E. de Schweinitz Professor

My education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Cleveland Clinic Foundation
  • Fellowship: University of California San Francisco

Spoken languages

English
English
中文 / 普通话
Chinese - Mandarin

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Jeng is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Pasricha ND, Kim SK, Farooq AV, Lindgren ES, Yan R, Seitzman GD, Chan MF, Shantha JG, Skondra D, Jeng BH, Chamberlain WD, Colby KA, Goldstein DA, Sobrin L, Kim IK, Singh K, Chambers WA, Boyd WM, Silverstein J, Pohlmann PR, Lu J, Glencer AC, Huppert LA, Chien AJ, Rugo HS, Esserman LJ. Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event Reporting , JAMA Ophthalmol, 144: 2026,62-68

Jacobs DS, Lee T, Asbell P, Shen J, Choulakian M, Holland GN, Baratz KH, Prescott CR, Colby K, Hochman JS, Troxel AB, Cohen E, Jeng BH. Stromal Keratitis in the Zoster Eye Disease Study: Lessons Learned , Am J Ophthalmol: 2026

Jeng BH. Neurotrophic Keratopathy in Herpes Zoster Ophthalmicus , Eye Contact Lens: 2025

Montufar Wright PE, Hicks PM, Mike EV, Armstrong ML, Ahmed O, Jeng B, Marioneaux S, Woreta F, Woodward MA. Impact of a Mentoring Program in Cornea: Findings from a Qualitative Study of Participants , Cornea: 2025

Lee V, Hultcrantz M, Petrone S, Lewis EW, Banna H, Lichtman E, Thulasi P, Quick AA, Jeng BH, Sunshine SB, Francis JH, Canestraro J, Farooq AV, Clements P, Robertson N, Burman M, McKevitt T, Struemper H, Weir L. Characterization of Belantamab Mafodotin-Induced Corneal Changes in Patients With Multiple Myeloma , JAMA Ophthalmol, 143: 2025,507-514

Cohen EJ, Troxel AB, Liu M, Hochman JS, Baratz KH, Mian SI, Choulakian MY, Warner DB, Lu Y, Twi-Yeboah A, Lee TF, Kim J, Lopez-Jimenez C, Laury SC, Jeng BH; ZEDS Trial Research Group. Low-Dose Valacyclovir in Herpes Zoster Ophthalmicus: The Zoster Eye Disease Randomized Clinical Trial , JAMA Ophthalmol, 143: 2025,269-276

Warner DB, Jeng BH, Kim J, Liu M, Troxel AB, Hochman JS, Baratz KH, Mian SI, Choulakian MY, Meyer JJ, Lu Y, Twi-Yeboah A, Lee TF, Lopez-Jimenez C, Laury SC, Cohen EJ; ZEDS Trial Research Group. Low-Dose Valacyclovir for Postherpetic Neuralgia in the Zoster Eye Disease Study: A Randomized Clinical Trial , JAMA Ophthalmol, 143: 2025,277-285

Prescott CR, Cohen EJ, Hochman JS, Troxel AB, Lu Y, Twi-Yeboah A, Jimenez CL, Mian SI, Mazen CY, Warner DB, Baratz KH, Jeng BH; ZEDS Trial Research Group. Baseline Participant Characteristics at Enrollment in the Zoster Eye Disease Study , Cornea, 43: 2024,1473-1480

Sherman MD, Asbell P, Warner D, Mian SI, Cohen E, Lee TF, Gillespie C, Jimenez CL, Baratz KH, Jeng B. Recruitment Strategies and Obstacles During the Zoster Eye Disease Study , Cornea, 44: 2024,1101-1106

Ali M, Dun C, Yenokyan G, Soiberman U, Jeng BH, Makary MA, Woreta F, Srikumaran D. Corneal Transplant Rejection Postvaccination Among Medicare Beneficiaries , Cornea, 43: 2024,1392-1396